1887

Abstract

As the biochemical detection of bovine papillomavirus type 4 E5 is problematic, a fusion form of E5 and the green fluorescent protein (GFP–E5) was constructed and its characteristics were examined. GFP–E5 was detected in cells by autofluorescence and immunoblotting. Like wild-type (wt) E5, GFP–E5 localized in the endomembranes and permitted anchorage-independent (AI) growth. However, unlike wt E5, cells expressing GFP–E5 became quiescent in low serum and failed to sustain expression of cyclins D1 and to inactivate retinoblastoma protein (pRb). The normal anchorage requirement for cyclin D1 and cyclin A expression was abolished in cells expressing wt E5 or GFP–E5, residual extracellular signal-regulated kinase (ERK 1/2) activity was not required to sustain cyclin D1 and cyclin A expression in suspension and deregulation of cyclin A–cyclin-dependent kinase (CDK) activity was sufficient to account for AI growth of cells expressing E5. Constitutive upregulation of the CDK inhibitor p27, characteristic of cells expressing wt E5, was not observed in those expressing GFP–E5; therefore, p27 deregulation is not required for E5-mediated AI growth.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.80313-0
2004-12-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/85/12/vir853585.html?itemId=/content/journal/jgv/10.1099/vir.0.80313-0&mimeType=html&fmt=ahah

References

  1. Alessi D. R., Cuenda A., Cohen P., Dudley D. T., Saltiel A. R. 1995; PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo . J Biol Chem 270:27489–27494 [CrossRef]
    [Google Scholar]
  2. Ashrafi G. H., Tsirimonaki E., Marchetti B., O'Brien P. M., Sibbet G. J., Andrew L., Campo M. S. 2002; Down-regulation of MHC class I by bovine papillomavirus E5 oncoproteins. Oncogene 21:248–259 [CrossRef]
    [Google Scholar]
  3. Assoian R. K. 1997; Anchorage-dependent cell cycle progression. J Cell Biol 136:1–4 [CrossRef]
    [Google Scholar]
  4. Assoian R. K., Schwartz M. A. 2001; Coordinate signaling by integrins and receptor tyrosine kinases in the regulation of G1 phase cell-cycle progression. Curr Opin Genet Dev 11:48–53 [CrossRef]
    [Google Scholar]
  5. Balmanno K., Cook S. J. 1999; Sustained MAP kinase activation is required for the expression of cyclin D1, p21Cip1 and a subset of AP-1 proteins in CCL39 cells. Oncogene 18:3085–3097 [CrossRef]
    [Google Scholar]
  6. Brugarolas J., Moberg K., Boyd S. D., Taya Y., Jacks T., Lees J. A. 1999; Inhibition of cyclin-dependent kinase 2 by p21 is necessary for retinoblastoma protein-mediated G1 arrest after γ -irradiation. Proc Natl Acad Sci U S A 96:1002–1007 [CrossRef]
    [Google Scholar]
  7. Burkhardt A., Willingham M., Gay C., Jeang K. T., Schlegel R. 1989; The E5 oncoprotein of bovine papillomavirus is oriented asymmetrically in Golgi and plasma membranes. Virology 170:334–339 [CrossRef]
    [Google Scholar]
  8. Cepko C. L., Roberts B. E., Mulligan R. C. 1984; Construction and applications of a highly transmissible murine retrovirus shuttle vector. Cell 37:1053–1062 [CrossRef]
    [Google Scholar]
  9. Chang H. W., Aoki M., Fruman D., Auger K. R., Bellacosa A., Tsichlis P. N., Cantley L. C., Roberts T. M., Vogt P. K. 1997; Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase. Science 276:1848–1850 [CrossRef]
    [Google Scholar]
  10. Conrad M., Bubb V. J., Schlegel R. 1993; The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16-kilodalton pore-forming protein. J Virol 67:6170–6178
    [Google Scholar]
  11. Danen E. H. J., Yamada K. M. 2001; Fibronectin, integrins, and growth control. J Cell Physiol 189:1–13 [CrossRef]
    [Google Scholar]
  12. Disbrow G. L., Sunitha I., Baker C. C., Hanover J., Schlegel R. 2003; Codon optimization of the HPV-16 E5 gene enhances protein expression. Virology 311:105–114 [CrossRef]
    [Google Scholar]
  13. Favata M. F., Horiuchi K. Y., Manos E. J. 11 other authors 1998; Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273:18623–18632 [CrossRef]
    [Google Scholar]
  14. Guadagno T. M., Assoian R. K. 1991; G1/S control of anchorage-independent growth in the fibroblast cell cycle. J Cell Biol 115:1419–1425 [CrossRef]
    [Google Scholar]
  15. Guadagno T. M., Ohtsubo M., Roberts J. M., Assoian R. K. 1993; A link between cyclin A expression and adhesion-dependent cell cycle progression. Science 262:1572–1575 [CrossRef]
    [Google Scholar]
  16. Henglein B., Chenivesse X., Wang J., Eick D., Bréchot C. 1994; Structure and cell cycle-regulated transcription of the human cyclin A gene. Proc Natl Acad Sci U S A 91:5490–5494 [CrossRef]
    [Google Scholar]
  17. Jackson M. E., Pennie W. D., McCaffery R. E., Smith K. T., Grindlay G. J., Campo M. S. 1991; The B subgroup bovine papillomaviruses lack an identifiable E6 open reading frame. Mol Carcinog 4:382–387 [CrossRef]
    [Google Scholar]
  18. Jirmanova L., Afanassieff M., Gobert-Gosse S., Markossian S., Savatier P. 2002; Differential contributions of ERK and PI3-kinase to the regulation of cyclin D1 expression and to the control of the G1/S transition in mouse embryonic stem cells. Oncogene 21:5515–5528 [CrossRef]
    [Google Scholar]
  19. Kain S. R., Adams M., Kondepudi A., Yang T. T., Ward W. W., Kitts P. 1995; Green fluorescent protein as a reporter of gene expression and protein localization. Biotechniques 19:650–655
    [Google Scholar]
  20. Kitagawa M., Higashi H., Jung H. K. 8 other authors 1996; The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2. EMBO J 15:7060–7069
    [Google Scholar]
  21. Klippel A., Escobedo M.-A., Wachowicz M. S., Apell G., Brown T. W., Giedlin M. A., Kavanaugh W. M., Williams L. T. 1998; Activation of phosphatidylinositol 3-kinase is sufficient for cell cycle entry and promotes cellular changes characteristic of oncogenic transformation. Mol Cell Biol 18:5699–5711
    [Google Scholar]
  22. Knudsen K. E., Fribourg A. F., Strobeck M. W., Blanchard J.-M., Knudsen E. S. 1999; Cyclin A is a functional target of retinoblastoma tumor suppressor protein-mediated cell cycle arrest. J Biol Chem 274:27632–27641 [CrossRef]
    [Google Scholar]
  23. Lin T. H., Chen Q., Howe A., Juliano R. L. 1997; Cell anchorage permits efficient signal transduction between Ras and its downstream kinases. J Biol Chem 272:8849–8852 [CrossRef]
    [Google Scholar]
  24. Lukas J., Müller H., Bartkova J., Spitkovsky D., Kjerulff A. A., Jansen-Dürr P., Strauss M., Bartek J. 1994; DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1. J Cell Biol 125:625–638 [CrossRef]
    [Google Scholar]
  25. Marchetti B., Ashrafi G. H., Tsirimonaki E., O'Brien P. M., Campo M. S. 2002; The bovine papillomavirus oncoprotein E5 retains MHC class I molecules in the Golgi apparatus and prevents their transport to the cell surface. Oncogene 21:7808–7816 [CrossRef]
    [Google Scholar]
  26. Morgan I. M., Campo M. S. 2000; Recent developments in bovine papillomaviruses. Papillomavirus Rep 11:127–132
    [Google Scholar]
  27. Munger K., Werness B. A., Dyson N., Phelps W. C., Harlow E., Howley P. M. 1989; Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J 8:4099–4105
    [Google Scholar]
  28. O'Brien V., Campo M. S. 1998; BPV-4 E8 transforms NIH3T3 cells, up-regulates cyclin A and cyclin A-associated kinase activity and de-regulates expression of the cdk inhibitor p27Kip1 . Oncogene 17:293–301 [CrossRef]
    [Google Scholar]
  29. O'Brien V., Ashrafi G. H., Grindlay G. J., Anderson R., Campo M. S. 1999; A mutational analysis of the transforming functions of the E8 protein of bovine papillomavirus type 4. Virology 255:385–394 [CrossRef]
    [Google Scholar]
  30. O'Brien V., Grindlay G. J., Campo M. S. 2001; Cell transformation by the E5/E8 protein of bovine papillomavirus type 4: p27Kip1, elevated through increased protein synthesis, is sequestered by cyclin D1-CDK4 complexes. J Biol Chem 276:33861–33868 [CrossRef]
    [Google Scholar]
  31. Pagès G., Lenormand P., L'Allemain G., Chambard J.-C., Meloche S., Pouysségur J. 1993; Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation. Proc Natl Acad Sci U S A 90:8319–8323 [CrossRef]
    [Google Scholar]
  32. Pennie W. D., Grindlay G. J., Cairney M., Campo M. S. 1993; Analysis of the transforming functions of bovine papillomavirus type 4. Virology 193:614–620 [CrossRef]
    [Google Scholar]
  33. Prendergast F. G., Mann K. G. 1978; Chemical and physical properties of aequorin and the green fluorescent protein isolated from Aequorea forskalea . Biochemistry 17:3448–3453 [CrossRef]
    [Google Scholar]
  34. Renshaw M. W., Ren X.-D., Schwartz M. A. 1997; Growth factor activation of MAP kinase requires cell adhesion. EMBO J 16:5592–5599 [CrossRef]
    [Google Scholar]
  35. Roovers K., Assoian R. K. 2000; Integrating the MAP kinase signal into the G1 phase cell cycle machinery. Bioessays 22:818–826 [CrossRef]
    [Google Scholar]
  36. Schapiro F., Sparkowski J., Adduci A., Suprynowicz F., Schlegel R., Grinstein S. 2000; Golgi alkalinization by the papillomavirus E5 oncoprotein. J Cell Biol 148:305–316 [CrossRef]
    [Google Scholar]
  37. Schulze A., Mannhardt B., Zerfass-Thome K., Zwerschke W., Jansen-Dürr P. 1998; Anchorage-independent transcription of the cyclin A gene induced by the E7 oncoprotein of human papillomavirus type 16. J Virol 72:2323–2334
    [Google Scholar]
  38. Sparkowski J., Anders J., Schlegel R. 1995; E5 oncoprotein retained in the endoplasmic reticulum/ cis Golgi still induces PDGF receptor autophosphorylation but does not transform cells. EMBO J 14:3055–3063
    [Google Scholar]
  39. Suprynowicz F. A., Sparkowski J., Baege A., Schlegel R. 2000; E5 oncoprotein mutants activate phosphoinositide 3-kinase independently of platelet-derived growth factor receptor activation. J Biol Chem 275:5111–5119 [CrossRef]
    [Google Scholar]
  40. Swanton C., Jones N. 2001; Strategies in subversion: de-regulation of the mammalian cell cycle by viral gene products. Int J Exp Pathol 82:3–13 [CrossRef]
    [Google Scholar]
  41. Wang H.-G. H., Rikitake Y., Carter C.M., Yaciuk P., Abraham S. E., Zerler B., Moran E. 1993; Identification of specific adenovirus E1A N-terminal residues critical to the binding of cellular proteins and to the control of cell growth. J Virol 67476–488
    [Google Scholar]
  42. Weber J. D., Raben D. M., Phillips P. J., Baldassare J. J. 1997; Sustained activation of extracellular-signal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phase. Biochem J 326:61–68
    [Google Scholar]
  43. Werness B. A., Levine A. J., Howley P. M. 1990; Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248:76–79 [CrossRef]
    [Google Scholar]
  44. Zerfass K., Schulze A., Spitkovsky D., Friedman V., Henglein B., Jansen-Dürr P. 1995; Sequential activation of cyclin E and cyclin A gene expression by human papillomavirus type 16 E7 through sequences necessary for transformation. J Virol 69:6389–6399
    [Google Scholar]
  45. Zhang Y., Lemasters J., Herman B. 1999; Secretory group IIA phospholipase A2 generates anti-apoptotic survival signals in kidney fibroblasts. J Biol Chem 274:27726–27733 [CrossRef]
    [Google Scholar]
  46. Zimmer M. 2002; Green fluorescent protein (GFP): applications, structure, and related photophysical behavior. Chem Rev 102:759–782 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.80313-0
Loading
/content/journal/jgv/10.1099/vir.0.80313-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error